Osaic Holdings
LGND icon

Osaic Holdings’s Ligand Pharmaceuticals LGND Stock Holding History

Osaic Holdings’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5M Buy
90,236
+32,086
+55% +$7.56M 0.03% 530
2026
Q1 		$11.6M Sell
58,150
-1,255
-2% -$248K 0.02% 819
2025
Q4 		$11.2M Sell
59,405
-41,337
-41% -$7.94M 0.02% 863
2025
Q3 		$17.8M Buy
100,742
+94,882
+1,619% +$14.1M 0.02% 676
2025
Q2 		$639K Buy
5,860
+3,695
+171% +$395K ﹤0.01% 2907
2025
Q1 		$228K Buy
2,165
+125
+6% +$14.1K ﹤0.01% 3519
2024
Q4 		$219K Sell
2,040
-1,786
-47% -$202K ﹤0.01% 3515
2024
Q3 		$383K Buy
3,826
+467
+14% +$47K ﹤0.01% 3114
2024
Q2 		$283K Buy
3,359
+2,722
+427% +$217K ﹤0.01% 3267
2024
Q1 		$46.6K Sell
637
-662
-51% -$48.8K ﹤0.01% 4804
2023
Q4 		$92.3K Sell
1,299
-244
-16% -$14.4K ﹤0.01% 4487
2023
Q3 		$92.4K Buy
1,543
+191
+14% +$12.6K ﹤0.01% 4569
2023
Q2 		$97.5K Buy
1,352
+13
+1% +$975 ﹤0.01% 4456
2023
Q1 		$98.5K Sell
1,339
-30
-2% -$2.13K ﹤0.01% 4463
2022
Q4 		$92.5K Sell
1,369
-957
-41% -$62.2K ﹤0.01% 4501
2022
Q3 		$125K Buy
2,326
+48
+2% +$2.82K ﹤0.01% 4174
2022
Q2 		$127K Buy
2,278
+128
+6% +$7.26K ﹤0.01% 4206
2022
Q1 		$151K Buy
2,150
+206
+11% +$14.9K ﹤0.01% 4256
2021
Q4 		$186K Sell
1,944
-81
-4% -$7.48K ﹤0.01% 4010
2021
Q3 		$175K Sell
2,025
-123
-6% -$9.51K ﹤0.01% 4030
2021
Q2 		$175K Sell
2,148
-731
-25% -$60.8K ﹤0.01% 3976
2021
Q1 		$273K Sell
2,879
-906
-24% -$85.6K ﹤0.01% 3466
2020
Q4 		$236K Sell
3,785
-1,716
-31% -$97.8K ﹤0.01% 3326
2020
Q3 		$332K Sell
5,501
-331
-6% -$22.6K ﹤0.01% 2802
2020
Q2 		$407K Buy
5,832
+124
+2% +$7.86K ﹤0.01% 2521
2020
Q1 		$257K Buy
+5,708
New +$324K ﹤0.01% 2667

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's LGND Position: Q2 2026 in Review

Osaic Holdings increased its Ligand Pharmaceuticals (LGND) stake by 55% in Q2 2026, buying an estimated $7.56M and bringing the position to 90,236 shares worth $28.5M. The position accounts for 0.03% of the portfolio, ranked #530.

Osaic Holdings first reported a position in LGND in Q1 2020 and has held it in 26 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Osaic Holdings held 90,236 shares of Ligand Pharmaceuticals worth $28.5M as of Q2 2026.
  • Osaic Holdings bought 32,086 Ligand Pharmaceuticals shares in Q2 2026, an estimated $7.56M.
  • Ligand Pharmaceuticals made up 0.03% of Osaic Holdings's portfolio in Q2 2026, its #530 holding.
  • Osaic Holdings first reported a position in Ligand Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.